Galmed Pharmaceuticals Ltd. (GLMD) Dividend History

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for liver diseases. The company's lead product candidate, Aramchol, is a bile acid derivative developed for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Galmed also explores other therapeutic options targeting liver and metabolic conditions.

Dividend History

Galmed Pharmaceuticals Ltd. currently does not pay dividends

Company News

  • Galmed Pharmaceuticals has launched a collaboration with Virginia Commonwealth University to investigate its drug Aramchol's potential in overcoming drug resistance in gastrointestinal cancers, including colorectal and liver cancers.

    Benzinga
  • Galmed Pharmaceuticals has identified novel pharmacodynamic blood markers for its lead compound Aramchol, which provide insights into the drug's potential beyond NASH treatment, including its impact on cardiometabolic and fibrotic conditions.

    Benzinga
  • Mainz Biomed shares jumped 16% in pre-market trading after the company announced submission for the FDA Breakthrough Device Designation for its next generation CRC screening test. Several other stocks also saw significant pre-market movement.

    Benzinga
    Featured Companies: ALBT BEEM GNLN HLIO INDV MYNZ NUWE TNXP
  • Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter. The company reported quarterly earnings of $1.31 per share, beating market estimates of $1.25 per share. PriceSmart’s quarterly sales came in at $1.29 billion versus expectations of $1.28 billion, according to data from Benzinga Pro. PriceSmart shares surged 4.6% to $86.90 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Marin Software Incorporated (NASDAQ: MRIN) shares rose 76.1% to $0.5054 in pre-market trading after the company announced upgrades to its Microsoft Corp (NASDAQ: MSFT) advertising integration. iCoreConnect Inc. (NASDAQ: ICCT) shares rose 46.4% to $1.64 in pre-market trading. iCoreConnect, last month, closed $2,375,000 convertible note financing. Nano Labs Ltd (NASDAQ: NA) gained 35.1% to $2.00 in pre-market trading. Nano Labs recently filed annual report on Form 20-F for fiscal year 2023. IN8bio, Inc. (NASDAQ: INAB) shares gained 20.2% to $1.31 in pre-market trading after the company announced new preclinical data from its non-signaling gamma-delta ...

    Benzinga
    Featured Companies: ASTI DXYZ INAB JAGX MRIN MSFT NA PRFX PSMT
  • Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Auddia Inc. (NASDAQ: AUUD) shares jumped 231.7% to $4.72 after the company announced the USPTO awarded it with U.S. Patent 11,935,520 for the core AI technology the company uses in its flagship faidr app to deliver ad-free AM/FM radio stations to paid subscribers. Longeveron Inc. (NASDAQ: LGVN) shares climbed 93.2% to $4.2499 after the company submitted paperwork for a share offering. UTime Limited (NASDAQ: WTO) gained 56.8% to $0.29 after the company completed a private placement. U Power Limited (NASDAQ: UCAR) climbed 48% to $6.96 after the company announced announced that its battery-swapping and sharing model for two-wheeled and light four-wheeled electric vehicles is poised for a formal commercial rollout in Wuhu, Anhui Province, China. Arrowroot Acquisition Corp. (NASDAQ: ARRW) rose 38.2% to $19.53. Destiny Tech100 Inc. (NASDAQ: DXYZ) jumped 33.8% to $79.30 after jumping around 77% on Friday. TechPrecision Corporation (NASDAQ: TPCS) rose 29.8% to $4.2837 after the company announced the termination of the agreement to acquire Votaw Precision Technologies. Adlai Nortye Ltd. (NASDAQ: ANL) gained 27.9% to $10.68. Connexa Sports Technologies Inc. (NASDAQ: CNXA) surged 26.8% to $0.3801. AXT, Inc. (NASDAQ: AXTI) rose 25.7% to $3.9089. AXT said it sees preliminary revenue of $22.4 million to $22.7 million for the first quarter. Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) climbed 24.4% to $8.70. Apartment Income REIT Corp. (NYSE: AIRC) gained 22.6% to $38.47. Blackstone Real Estate will take AIR Communities private for approximately $10 billion. GD Culture Group Limited (NASDAQ: GDC) rose 22% to $1.1195. Outset Medical, Inc. ...

    Benzinga
Dividend data last updated 06/07/2025 05:16:51 UTC